DNDN Related Analyst Ratings

Nov 12, 2009 08:48 AM Leerink Says Takeaway From Dendreon's (DNDN) Q3 Report is the Busy Preparations for Provenge

Oct 23, 2009 09:33 AM Canaccord Adams Starts Dendreon (DNDN) at Buy, Sets 'Street High' Price Target

Oct 23, 2009 09:17 AM Canaccord Adams Starts Dendreon (DNDN) with a Buy, $43 tgt

Sep 22, 2009 06:54 AM Leerink Swann Starts Dendreon (DNDN) at Overweight

Sep 18, 2009 09:19 AM Deutsche Bank Said FDA Guidance Documents Support Dendreon's (DNDN) Provenge Approval

Aug 11, 2009 01:13 PM Merriman Curhan Reiterates Bullish Stance On Dendreon (DNDN) Following Q2 Results/Call

Jul 23, 2009 10:01 AM Needham Comments on "Who's Next" In Biotech After Bristol-Myers (BMY) Buys Medarex (MEDX)

Jul 6, 2009 07:55 AM Merriman Curhan Boosts Price Target Range on Dendreon (DNDN) to $49-$50

Jun 30, 2009 09:11 AM Morgan Joseph Starts Dendreon (DNDN) at Hold, Waiting for Better Entry Point

Jun 22, 2009 07:21 AM McAdams Wright Ragen Upgrades Dendreon (DNDN) to Hold

Jun 10, 2009 07:06 AM Citigroup Starts Dendreon (DNDN) at Buy, $35 Target

Jun 5, 2009 07:04 AM Deutsche Bank Starts Dendreon (DNDN) At Buy, Says Provenge Will Be a "Blockbuster"

May 18, 2009 10:16 AM Needham Discusses Next Steps For Dendreon's (DNDN) PROVENGE

May 11, 2009 11:19 AM Dendreon (DNDN) Sees Continued Upside On 'Table-Pounding' Analyst Comments

May 8, 2009 08:01 AM McAdams Wright Downgrades Dendreon (DNDN) to Sell

Apr 29, 2009 10:59 AM Needham Upgrades Dendreon (DNDN) To Buy, With 'Street High' $38 Price Target

Apr 29, 2009 08:24 AM Dendreon (DNDN) Bear Now A Full-Fledged Bull

Apr 29, 2009 07:53 AM Wachovia Upgraded Dendreon (DNDN) to Outperform, Expects PROVENGE Approval

Apr 22, 2009 08:31 AM Merriman Curhan Upgrades Dendreon (DNDN) to Buy

Apr 20, 2009 11:07 AM Lazard Upgrades Dendreon (DNDN) to Buy

Apr 16, 2009 08:34 AM Bearish Dendreon (DNDN) Analyst Throws In The Towel, Upgrades to Hold

Apr 14, 2009 03:45 PM Rodman & Renshaw Upgrades Dendreon (DNDN) to Market Outperform

Apr 14, 2009 12:56 PM Needham & Co Positive About Dendreon (DNDN) PROVENGE Results, Maintains Hold On Valuation

Apr 14, 2009 11:57 AM Merriman Curhan Upgrades Dendreon (DNDN) to Neutral

Apr 14, 2009 10:49 AM Brean Murray Remains Unconvinced On Dendreon's (DNDN) PROVENGE Despite News and Share Surge

Apr 13, 2009 09:39 AM Brean Murray Issues Last 2 Cents On Dendreon's (DNDN) PROVENGE - "It Will Fail"

Apr 6, 2009 08:45 AM Brean Murray Comments on Dendreon (DNDN) Following Friday's Run-Up

Oct 6, 2008 02:30 PM Wachovia Cautious on Interim Data from Dendreon's (DNDN) Provenge Trial; Says Rally Will Be 'Short-Lived'

Nov 16, 2007 01:57 PM Brean Murray Continues To Think Dendreon's (DNDN) IMPACT Trial Will Fail

Oct 10, 2007 06:20 PM Wachovia Starts Dendreon (DNDN) at Market Perform

Aug 8, 2007 09:55 AM Needham Reiterates Their Hold Rating on Dendreon Corporation (DNDN)

Jul 24, 2007 10:13 AM Dendreon (DNDN): Brean Murray Says Crossover Trial Design Confounds Survival Analysis

Jul 12, 2007 08:49 AM JMP Securities Downgrades Dendreon (DNDN) to Market Underperform

Jul 5, 2007 07:27 AM Brean Murray Said Article on Dendreon's Provenge Doesn't Increase Chances

May 24, 2007 10:22 AM JMP Securities downgrades Dendreon (DNDN) to Market Perform

May 10, 2007 08:24 AM Banc of America downgrades Dendreon (DNDN) to Sell

May 9, 2007 10:45 AM Next Generation Research downgrades Dendreon (DNDN) to Sell

May 9, 2007 10:17 AM Needhman downgrades Dendreon (DNDN) to Hold

May 3, 2007 09:39 AM Next Generation Equity Research Upgrades Dendreon (DNDN) to Buy and Price Target to $25

May 3, 2007 08:07 AM AG Edwards Starts Dendreon (DNDN) at Hold

May 2, 2007 10:24 AM Needham Remains Positively Inclined Toward FDA CBER Approval for Dendreon (DNDN) Provenge

Apr 24, 2007 09:53 AM Banc of America Positive on Dendreon (DNDN)

Apr 24, 2007 09:28 AM Dendreon (DNDN) option implied volatility & volume suggests continued price Fluctuations

Apr 24, 2007 08:57 AM Banc of America said Dendreon (DNDN) Provenge approval likely - Bloomberg

Apr 16, 2007 10:12 AM Brean Murray Notes Dendreon (DNDN) PROVENGE Panelist Voices Concerns to FDA

Apr 11, 2007 09:12 AM JMP Securities downgrades Dendreon (DNDN) to Market Outperform

Apr 10, 2007 02:32 PM MDB Capital questions whether the FDA will heed the advice of the advisory panel on Dendreon (DNDN)

Mar 30, 2007 09:48 AM Dawson James Said Dendreon News Could Be a Positive for Introgen Therapeutics (INGN)

Mar 30, 2007 07:43 AM Dendreon (DNDN) implied volatility Elevated into FDA Advisory Panel saying Provenge safe

Jul 5, 2006 11:48 AM JMP Securities upgrades Dendreon (DNDN) to Strong Buy